Silodosin for enlarged prostate and ejaculation outcomes
Part of Kidney & urinary clinical trials.
This trial tests how a medication called silodosin (8 mg once daily) affects symptoms and ejaculatory function in men with an enlarged prostate causing urinary problems. It aims to understand both the benefits and side effects of this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 40 or older
- You have been diagnosed with lower urinary tract symptoms due to an enlarged prostate (benign prostatic obstruction)
- You have not taken silodosin or similar alpha-blocker medications in the last 3 months
- You have not had prostate surgery or pelvic radiation, and do not have prostate or bladder cancer
- You have not taken medications that affect sexual function (like PDE5 inhibitors for erectile dysfunction) in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two prostate medications (tamsulosin and silodosin) to see how they might affect the iris — the colored part of your eye. It may help doctors choose the best option for men who also have concerns about their eyes.
This study compares two medications for an enlarged prostate to see how they affect the size of the pupil and the thickness of a layer in the back of the eye. It may help you understand potential eye-related side effects of these treatments.
This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.
This study tests whether silodosin, a medication that relaxes bladder muscles, can help women with multiple sclerosis who have bothersome urinary symptoms. The goal is to see if it can reduce urgency, frequency, and other lower urinary tract problems.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests whether increasing your prostate medication (tamsulosin) or switching to a different medication (silodosin) helps you urinate normally again after a sudden blockage caused by an enlarged prostate. The goal is to help you avoid long-term catheter use.
Hear when a new Benign Prostate Obstruction (BPO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.